EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

European Union seeks input from rival pharmaceutical firms on Novo Holdings' $16.5 billion acquisition of Catalent.

European Union regulators can either clear the deal with or without ... The $16.5 billion deal, announced in February, ...

European shares ended lower on Wednesday, following a broad rally earlier in the session, hurt by a drop in utilities shares ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

We recently compiled a list of the 8 Best European Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical company that focuses on diabetes care and obesity treatment. The company is one of the world’s leading producers of insulin and other ...

The former U.S. President had vowed to impose a 10% tariff on imports from all countries if he won, and said the European ...

Trump also vowed to impose a 10% tariff on imports from all countries if he won, and said the European Union would have to ... quarterly sales of its popular Wegovy weight-loss drug and narrowed ...

ESSENCE is a double-blinded, 240-week study that involves 1,200 adults with MASH and stage two or three liver fibrosis.